Memorial Sloan Kettering Cancer Center
ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpelisib, in ER+/HER2- Advanced BC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Komal Jhaveri
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Komal Jhaveri
Login to view comments.
Click here to Login